Decreased expression of <i>MT1E</i> is a potential biomarker of prostate cancer progression.

Oncotarget · 2017 · PMC5617458 · PMID 28977898

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

borderline significancep = 0.057so close (0.05 < p ≤ 0.1)

Kaplan-Meier analysis revealed that BCR-free survival was significantly impacted by pT (p < 0.001), G (p < 0.001), and MT1E expression (p = 0.003; Figure 2G–2I ), while GPR52 expression showed a borderline significance (p = 0.057).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.